Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,501 to 1,520 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Expression of Methyltransferase-Like 3 in Oral Precancerous Lesions and Oral Squamous Cell Carcinoma. | Eur J Dent | 2023 | 35785826 | PubTator, text mining | PubMed |
| m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma. | J Cancer Res Clin Oncol | 2023 | 35780396 | PubTator, text mining | PubMed |
| N6 -methyladenosine-modified circRNA RERE modulates osteoarthritis by regulating β-catenin ubiquitination and degradation. | Cell Prolif | 2023 | 35733354 | PubTator, text mining | PubMed |
| Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer. | J Cancer Res Clin Oncol | 2023 | 35731272 | PubTator, text mining | PubMed |
| Construction and validation of a nomogram based on N6-Methylandenosine-related lncRNAs for predicting the prognosis of non-small cell lung cancer patients. | Cancer Med | 2023 | 35726651 | PubTator, text mining | PubMed |
| Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma. | Cancer Med | 2023 | 35668574 | PubTator, text mining | PubMed |
| Role of RNA modifications in carcinogenesis and carcinogen damage response. | Mol Carcinog | 2023 | 35560957 | PubTator, text mining | PubMed |
| Characteristics of N6-methyladenosine Modification During Sexual Reproduction of Chlamydomonas reinhardtii. | Genomics Proteomics Bioinformatics | 2023 | 35550876 | PubTator, text mining | PubMed |
| Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. | Oral Dis | 2023 | 35467063 | PubTator, text mining | PubMed |
| Parallel-reaction monitoring revealed altered expression of a number of epitranscriptomic reader, writer, and eraser proteins accompanied with colorectal cancer metastasis. | Proteomics | 2023 | 35443089 | PubTator, text mining | PubMed |
| AS3MT facilitates NLRP3 inflammasome activation by m6A modification during arsenic-induced hepatic insulin resistance. | Cell Biol Toxicol | 2023 | 35226250 | PubTator, text mining | PubMed |
| Effect of N6 adenylate methylation on myocardial hypertrophy through METTL14 regulation. | Panminerva Med | 2023 | 35179014 | PubTator, text mining | PubMed |
| Specific Regulation of m6A by SRSF7 Promotes the Progression of Glioblastoma. | Genomics Proteomics Bioinformatics | 2023 | 34954129 | PubTator, text mining | PubMed |
| METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance. | Oral Dis | 2023 | 34807506 | PubTator, text mining | PubMed |
| METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. | Cell Biol Toxicol | 2023 | 34648132 | PubTator, text mining | PubMed |
| Transcriptome-wide Dynamics of m6A mRNA Methylation During Porcine Spermatogenesis. | Genomics Proteomics Bioinformatics | 2023 | 34543723 | PubTator, text mining | PubMed |
| Circular RNAs: Biomarkers of cancer. | Cancer Innov | 2022 | 38089761 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognostic impact and immune implication of KIAA1429 in lung adenocarcinoma. | Cancer Innov | 2022 | 38089085 | PubTator, text mining | PubMed |
| Correlative Study on the Relationship between the Expression of m6a-Related Genes and the Prognosis and Immunotherapy of Soft Tissue Sarcoma. | Biomed Res Int | 2022 | 38024481 | PubTator, text mining | PubMed |
| Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner. | Turk J Biol | 2022 | 37529797 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=76